Whole Exome Sequencing Market Set To Reach At $884.1 Million by 2018

The services market accounted for the largest share of the global WES products and services market in 2013.

Persone Rohan Unit
Luoghi Europa, Asia, Cina, America del Nord, India, Germania, Pune, Stati Uniti d'America, Maharashtra, Wé, Our
Organizzazioni Eurofins Genomics Inc., Beijing Genomics Institute, Agilent Technologies, Roche NimbleGen Inc., Thermo Fisher Scientific Inc., Life Technologies, WES systems, Whole Exome Sequencing Market, Direzione Nazionale Antimafia
Argomenti commercio, economia, impresa

25/feb/2016 09.51.34 MarketsandMarkets Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.
The “Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018” analyzes and studies the major market drivers, threats, opportunities, and challenges.
 
Browse 80 market data tables and 26 figures spread through 220 pages and in-depth TOC on "Whole Exome Sequencing Market"
http://www.marketsandmarkets.com/Market-Reports/whole-exome-sequencing-market-107180258.html
Early buyers will receive 10% customization on this report.
 
This report studies the global Whole Exome Sequencing (WES) market over the forecast period of 2013–2018. This market was valued at $326.6 million in 2013 and is poised to grow at a CAGR of 22%, to reach $884.1 million by 2018.
 
Advances in DNA sequencing have transformed genomics and paved the way for whole exome sequencing in research. Whole exome sequencing is cost-efficient and quick, as compared to whole-genome sequencing. Sequencing the exome is also considered more effective, as exons possess 85% of disease traits. Thus, WES systems, kits, and services have seen increased adoption by researchers as they not only simplify work but also save time.
 
Technological advancements in sequencing systems, global alliances amongst leading research institutes to boost drug discovery, and an increase in life science and R&D expenditure are the key factors that are expected to drive the growth of this market. Primary factors that are restraining the growth of this market include high instrument costs, the need for skilled professionals, and high reliance on grants and funds.
 
Get The Sample Copy:
http://www.marketsandmarkets.com/requestsample.asp?id=107180258
 
The global whole exome sequencing market is categorized into five broad segments, namely, products and services, technologies, applications, end users, and geography. The global WES products and services market, by products, comprises systems and kits. The kits market is further segmented into DNA fragmentation, end repair, A-tailing, size selection kits, library preparation kits, and target enrichment kits. The WES products and services market, by services, comprises sequencing and data analysis services. The services market accounted for the largest share of the global WES products and services market in 2013.
 
The whole exome sequencing market, by applications, includes diagnostics, drug discovery and development, personalized medicine, and animal and plant research. In 2013, the diagnostics market held the largest share of the global WES applications market. The market, by end users, comprises research centers, academic and government institutions, hospitals and clinics, and pharmaceutical and biotech companies, among others. In 2013, research centers and academic and government institutions accounted for the largest share of the global market, by end users. On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia and Rest of the World (RoW).
 
Speak to Research Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=107180258
 
This global whole exome sequencing market was valued at $326.6 million in 2013 and is expected to grow at a CAGR of 22.0% from 2013 to 2018, to reach $884.1 million by 2018. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is expected to maintain its leadership in the market in the coming years. Growth in the North American market is likely to be driven by factors such as the increasing use of exome sequencing in rare disease research, increased government funding, and large number of sequencing-related conferences and annual meetings hosted by the U.S.
 
The major players in the global whole exome sequencing market include Illumina, Inc. (U.S.) Life Technologies (acquired by Thermo Fisher Scientific, Inc.) (U.S.), Roche NimbleGen, Inc. (U.S.), Agilent Technologies (U.S.), BGI (Beijing Genomics Institute, China), Eurofins Genomics, Inc. (Germany), Sengenics (U.S.), GENEWIZ, Inc. (U.S.), Knome, Inc. (U.S.), Macrogen, Inc. (South Korea), and Ambry Genetics (U.S.), among others.
 
About MarketsandMarkets:
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
 
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
 
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
 
Contact:
Mr. Rohan

Unit No. 802, 8th Floor, 
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013, 
Maharashtra, India.
Tel: +1-888-6006-441.
 
Get your own FREE website, FREE domain & FREE mobile app with Company email.  
Know More >
blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl